A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
In 2020 the total market size for GLP-1 drugs was less than $4 billion . That same year, Novo Nordisk® paid $1.8 billion to purchase Emisphere's® SNAC drug delivery technology which was subsequently ...
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...
NICE has opened a consultation on the possible mass rollout of tirzepatide to millions of people in England over the next decade.
After Wegovy and Ozempic by pharmaceutical company Novo Nordisk, Netherlands residents will soon also have access to another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback